Important note

This AI stock analysis for Tempus AI is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!


Tempus AI - AI Stock Analysis

Analysis generated March 18, 2025

Tempus AI is a leading player in the artificial intelligence sector, specializing in healthcare and precision medicine. Utilizing advanced machine learning and data analytics, Tempus AI aims to revolutionize how medical professionals diagnose and treat diseases. The company’s technology platform integrates clinical and molecular data, providing actionable insights for healthcare providers. With a focus on improving patient outcomes, Tempus AI has been gaining traction in the medical community and has shown consistent growth in terms of revenue and market presence.

Fundamental Analysis

Tempus AI reported revenue of $181 million for the last quarter, marking a 9.01% increase compared to the previous quarter. This quarterly growth is a positive indicator of the company's ongoing expansion and operational efficiency. More impressively, the revenue shows a year-over-year increase of 32.98%, confirming robust long-term growth.

Net income for the last quarter was $76 million, an 86.27% increase compared to the previous quarter, reflecting strong profitability. However, the year-over-year net income has decreased by 41.95%, which raises some concerns about long-term sustainability and profitability challenges compared to last year.

EBITDA for the last quarter was $51 million, a significant increase of 90.29% from the previous quarter but a 56.15% decrease from the same quarter last year. These mixed signals indicate strong short-term performance but also highlight potential operational or market challenges when viewed over a longer period.

Additionally, insider selling has been observed in the last couple of months, which can be perceived as a bearish signal from those who know the company best.

Technical Analysis

The current stock price of Tempus AI is $46.45, a 43.32% decrease from a month ago, indicating a possible short-term concern. However, on a longer-term scale, the stock price is up 15.40% compared to a year ago, suggesting an overall positive trend.

The trend is currently bearish. The Simple Moving Average over 10 days (SMA10) is at $46.54, lower than the previous SMA10 of $46.80, reinforcing the short-term downward trend. The Relative Strength Index (RSI) is at 40.7, indicating a neutral condition, suggesting neither overselling nor overbuying in the current trading environment.

Alternative Data Analysis

From an alternative data perspective, Tempus AI shows promising signs of growth and expansion. The company has 126 open positions as per popular job boards, up by 50% in the last couple of months. This expansion in hiring is generally a positive indicator for future growth and operational scaling.

The business outlook among employees remains neutral, which neither boosts nor diminishes investor confidence significantly. Customer acquisition metrics also show a bullish trend, with an estimated 220,000 visitors to the webpage, a 102% increase in recent months. This suggests growing interest and potentially more customers.

Customer engagement has increased with their Instagram followers up by 27% to 2,500 and Twitter followers up by 36% to 9,600 in the last couple of months. This growth in social media following indicates heightened interest and potentially a growing brand presence.

The AltIndex’s AI score for Tempus AI stands at 68, which signals a buy recommendation, amalgamating fundamental, technical, and alternative data analyses.

Conclusion and Recommendation

Tempus AI boasts strong revenue growth and a positive long-term stock price trend, suggesting a promising future. The company's recent profitability metrics show strong short-term gains but raise concerns when compared to last year. Technical indicators present a short-term bearish trend, but the alternative data points to robust potential growth and heightened customer interest.

Given the mixed short-term signals but strong long-term prospects bolstered by customer and employee growth, Tempus AI may be a promising stock to consider for long-term investors. Based on the current analysis encompassing fundamental, technical, and alternative data aspects, the recommendation is cautiously optimistic with a tilt towards a buy decision.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.